Skip to content
The Quiet LedgerBeyond the noise. On the record.
hres 242 · 116th Congress · House

Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.

Sign in to watch / set alerts
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Cosponsors
6 current · 6 total
Actions
3
Roll calls
0
Criterion breakdown8 criteria · max 90
No grade to break down.
Actions (3)
DateTimeAction
2019-03-18Referred to the House Committee on Energy and Commerce.
2019-03-18Introduced in House
2019-03-18Introduced in House

The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.